Starna Scientific Limited
The principal activity of the company is the development and manufacture of traceable reference materials and precision optical components for laboratory and instrument users. Sales are achieved through a mix of direct relationships and established distributors across mature markets. Starna’s reputation and differentiation are built on accreditation (ISO 9001, ISO/IEC 17025, and ISO 17034) and metrology expertise supported by robust certification. The model emphasises quality, dependable lead times, and technical support. Trading conditions were mixed, with steady demand in core lines and selective input cost pressure. Revenue was broadly resilient at £10.0m ( 2024 : £10.16m). Gross margin improved to 50% ( 2024 : 48%), reflecting an evolving product mix and disciplined cost control. Our ISO 9001, ISO/IEC 17025, and ISO 17034 accreditations continue to underpin customer confidence and support pricing power through demonstrable quality and traceability. The company considers both revenue and gross margin as key performance indicators. UK domestic tax changes have further increased labour costs due to higher NIC rates and reduced thresholds. Conversely, potential government investment in technology could support future demand for our products. Operating environment and logistics. Disruption to global sea freight routes had a limited impact on outbound sales. However, certain raw materials experienced longer inbound lead times and cost variability. These effects were managed through forward purchasing, alternative sourcing where appropriate and pragmatic inventory buffers. Overlaps between raw material chains drove price and availability pressures for specific inputs. We mitigate this through supplier diversification and the qualification of secondary sources where possible.
Revenue
£10.2m
▼ -12.1% vs prior ~12m period
Profit after tax
£868k
Margin 8.5%
Employees
98
▼ -3.0% vs prior ~12m period
Net assets
£16.7m
Total assets £19.0m
Financial history
Revenue by accounting period
6 periods available · ▲ growth ▼ decline
| Period end | Revenue | Growth | Profit before tax | Employees | Net assets |
|---|---|---|---|---|---|
| 30 Apr 2025 | — | — | £2.3m | 98 | £16.7m |
| 30 Apr 2024 | — | — | £1.5m | 101 | £15.8m |
| 30 Apr 2023 | — | — | £1.0m | 103 | £15.1m |
| 30 Apr 2022 | £10.2m | ▼ -12.1% | £1.1m | 100 | £14.7m |
| 30 Apr 2021 | £11.6m | ▲ +28.9% | £4.8m | 97 | £14.3m |
| 30 Apr 2020 | £9.0m | — | £2.9m | 95 | £11.4m |
Latest available figures
Period ending 30 Apr 2022. “Not available” means the figure is not in the accounts we hold. We do not estimate missing figures.
Profit & loss
- Revenue
- £10.2m
- Gross profit
- Not available
- Operating profit
- £865k
- Profit before tax
- £1.1m
- Profit after tax
- £868k
Balance sheet
- Total assets
- £19.0m
- Cash
- £7.0m
- Total liabilities
- £2.3m
- Net assets
- £16.7m
- Revenue per employee
- Not available
Similar companies
| Company | Industry | Location | Revenue | Growth | Employees |
|---|---|---|---|---|---|
| Harlette Capital Limited 08565376 | Manufacturing | London | £100.0m | – 0.0% | 2 |
| Usp Steels Limited 10437761 | Manufacturing | Dudley | £99.2m | ▲ +2.7% | 82 |
| Pickstock Foods Ltd 11412792 | Manufacturing | Swadlincote | £97.3m | ▲ +18.0% | 152 |
| Crescent Pharma Limited 04750933 | Manufacturing | Basingstoke | £96.5m | ▼ -8.4% | 55 |
| B.H.C. Limited NI029649 | Manufacturing | Enniskillen | £96.0m | ▼ -31.0% | 406 |
Other manufacturing companies in London
| Company | Industry | Location | Revenue | Growth | Employees |
|---|---|---|---|---|---|
| Ds Smith Packaging Limited 00630681 | Manufacturing | London | £687.2m | ▼ -9.8% | 3,314 |
| Baird & Co. Limited 02269558 | Manufacturing | London | £471.1m | ▲ +25.5% | 58 |
| Vapes-Bars Ltd 13540609 | Manufacturing | London | £162.6m | ▼ -5.4% | 6 |
| Keter UK Limited 04992337 | Manufacturing | London | £113.0m | ▼ -11.2% | 210 |
| Cepac Limited 03373762 | Manufacturing | London | £111.2m | ▼ -4.6% | 450 |